Cargando…
Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial
BACKGROUND: Commensal microbiota deteriorate in critically ill patients. The preventive effects of probiotic/synbiotic therapy on microbiota and septic complications have not been thoroughly clarified in patients with sepsis. The objective of this study was to evaluate whether synbiotics have effect...
Autores principales: | Shimizu, Kentaro, Yamada, Tomoki, Ogura, Hiroshi, Mohri, Tomoyoshi, Kiguchi, Takeyuki, Fujimi, Satoshi, Asahara, Takashi, Yamada, Tomomi, Ojima, Masahiro, Ikeda, Mitsunori, Shimazu, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161427/ https://www.ncbi.nlm.nih.gov/pubmed/30261905 http://dx.doi.org/10.1186/s13054-018-2167-x |
Ejemplares similares
-
Gut Microbiota and Probiotics/Synbiotics for Modulation of Immunity in Critically Ill Patients
por: Shimizu, Kentaro, et al.
Publicado: (2021) -
Impaired balance between coagulation and fibrinolysis plays a prominent role in patients with sepsis
por: Umemura, Y, et al.
Publicado: (2014) -
Probiotic/Synbiotic Therapy for Treating Critically Ill Patients from a Gut Microbiota Perspective
por: Shimizu, Kentaro, et al.
Publicado: (2012) -
Hematological Phenotype of COVID-19-Induced Coagulopathy: Far from Typical Sepsis-Induced Coagulopathy
por: Umemura, Yutaka, et al.
Publicado: (2020) -
Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study
por: Yamakawa, Kazuma, et al.
Publicado: (2011)